SymBioSys I - K.U.Leuven Center for Computational Systems Biology
From 01-11-2005 to 31-10-2012
Website: http://www.kuleuven.be/symbiosys
Description
SymBioSys, the K.U.Leuven Center for Computational Systems Biology, is an interfaculty platform that brings together top expertise in bioinformatics, statistics, and life sciences from 7 K.U.Leuven partners. Its ambition is to become worldwide a leading center for computational systems biology. The consortium builds upon existing bioinformatics research and collaborations between the consortium partners. The growth of bioinformatics at the K.U.Leuven has been driven so far by a strong need for bioinformatics expertise within the university and outside, creating numerous research opportunities. At this point however, there is an urgent need for a larger scale collaborative structure such as this center. Indeed, the amount and the complexity of the data, which biologists now generate using high-throughput “omics” technologies, forces a paradigm shift upon the research methodology that can only be tackled in an intimate collaboration between biology and computation. The consortium aspires to excellence in three problems in computational systems biology: (1) gene prioritization by genomic data fusion, (2) regulatory module discovery, and (3) network inference. These problems have been chosen because of their high level of innovation, the already established expertise, and the biological importance in the respective fields of research. The proposal consists of three workpackages corresponding to these problems and where the work is further split into (1) methodological development in computational biology, (2) methodological deepening in collaboration with the statistics partners, and (3) two biological cases in collaboration with the biological partners.Team
- Kathleen Marchal, Co-promoter
- Yves Moreau, Co-promoter
- Bart De Moor, Promoter
Financing
Funding: KU Leuven - Internal Funding KU Leuven
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.